Risk assessment guideline focus group meeting

The Antimicrobials Working Party of the European Medicines Agency's Committee for Medicinal Products for Veterinary Use (CVMP) is holding a focus group meeting with stakeholders to discuss the revision of the antimicrobial veterinary medicinal product risk assessment guideline, following a public consultation on the draft revised guideline ending on 31 October 2018. The meeting will focus on topics identified during this public consultation. This guideline aims to provide guidance to marketing authorisation applicants on the data requirements and methodology to be used for assessing the risk to public health from antimicrobial resistance from use of those products in food-producing animals.